chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Patient complained about soreness and redness at injection site.
Age: 39.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Injection site pain, Tenderness
Clinical narrative: Stinging pain in right arm during and after injection lasting several days. Pain remains when arm is touched 9 days after injection.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Medical assistant administered a flu vaccine on a patient that had already received one on 9/20/2024.  Patient was notified of vaccination error as well as PCP. No s/s adverse reaction noted
Age: 64.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Bruxism, Muscle tightness, Pain
Clinical narrative: Patient received 2 vaccinations around 9:30am at an offsite pharmacy vaccination clinic in her long term care facility. At 11:30am patient was in her room and presented with extreme all over body pain, teeth clenching and grinding, inability to verbalize, and inability to move from her laying position. Nursing staff called for pharmacy staff asking ?do you have an Epi?? Pharmacy staff took the offsite procedure and emergency kit to the patient?s room. Upon evaluation by pharmacist, patient was unable to vocalize and grinding teeth in pain. Pharmacist offered Benadryl and nursing staff declined, again asking for the epinephrine. Pharmacist briefly counseled patient that epinephrine is known to cause severe headaches and asked patient to verbally consent to epinephrine administration. Patient was unable to answer. Pharmacist again asked for consent and the patient softly strained consent with the words ?do it.? Pharmacist administered epinephrine at 11:41am and advised staff to call EMS. Pharmacist asked patient at 11:43am if they perceived less pain and the patient was able to verbalize that it did not hurt less. Pharmacist tried to palpate pulse in both the left and right arms and could not as patient?s muscles were still tense. This is when nursing staff informed the pharmacist that patient had been given her scheduled oral liquid morphine for her M.S. prior to calling for pharmacy staff. At 11:45am patient visibly relaxed and pharmacist was able to inquire about pain and ask about what the patient ate for breakfast. Patient was able to verbalize without difficulty that her body was ?calm?, her head was ?calm? and she was able to recall what she ate for breakfast. EMS arrived as patient was answering these questions. Pharmacist let EMS know what had been done and asked for EMS to obtain vials. EMS did a quick verbal evaluation with patient regarding any tongue swelling or hives, read pulse ox and heart rate which were all within normal range. EMS then dismissed pharmacy as they thought it was not anaphylaxis and possibly related to patient?s neurological history. Before leaving the room pharmacist recommended this patient only receives vaccines at a medical facility.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Vaccine was drawn up with sterile water instead of Sodium Chloride for diluent.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient started noticing redness and swelling in her arm where she received the injection, some hours later. The next day the redness and swelling had spread and she started feeling pain in the same area. The redness covers at least half of her upper arm.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Oral mucosal blistering
Clinical narrative: PATIENT EXPERIENCED LIP SWELLING AND BLISTER FORMS IN THE MOUTH APPROX 45 MINUTES AFTER ADMINISTRATION PER PATIENT, WAS REPORTED TO RPH 1 WEEK LATER. PT DID NOT REQUIRE MEDICAL ATTENTION
Age: 82.0
Sex: F
Vaccine: FLU3
Symptoms: Diarrhoea, Myalgia, Pyrexia
Clinical narrative: that night muscle aches, which are improved by tylenol, low grade fever, slight diarrhea
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Vision blurred
Clinical narrative: Patient reported having blurry vision one day after receiving the vaccine.  Blurry vision is present when both eyes are open, however, vision is normal when one is closed and the other is open.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered
Clinical narrative: The patient came in yesterday asking for a flu shot. When entered into the system, there was no warning listing that the patient had received the vaccine before, and the vaccine was processed through insurance. Today we have received notification that the patient had received this vaccine back on August 10th, making this his second flu shot this year. The patient is unharmed and is not upset about the error.
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Incorrect diluent was used to draw up vaccines. Used sterile water instead of Sodium Chloride.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: The MA who administered the covid vaccine to patient diluted the vaccine with 1.5 mls of normal saline  instead of 1.1 mls of normal saline. This resulted in the patients getting under-dosed (since it was over diluted). PATIENT DID NOT HAVE ANY ADVERSE REACTION.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Incorrect diluent used to draw up vaccine. Used sterile water instead of sodium chloride.
Age: 61.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was 61 at the time of the vaccination. Pharmacist did not catch that the patient was not 65 years or older and gave the patient a vaccination intended for patients aged 65 and older. There were no adverse reactions experienced by the patient.
Age: 86.0
Sex: M
Vaccine: VARZOS
Symptoms: Product preparation issue
Clinical narrative: Two vials of powder was mixed with one diluent.  One pharmacist had mixed and had a medical emergency and the second pharmacist came to finish and mixed already mixed product to another vial of powder.  This was administered to patient
Age: 57.0
Sex: M
Vaccine: UNK
Symptoms: Psoriasis
Clinical narrative: Psoriasis went to dermatologist and and was prescribed Clobetasol Propionate Ointment USP, 0.05%. Apply 2x per day. doesn't really help much.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Third dose of MMR given to patient in error . Second dose of flu given less than 30 days to  the one administered on 8/27/2024
Age: 3.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Product preparation error
Clinical narrative: Incorrect diluent used to draw up covid vaccine. Used sterile water instead of sodium chloride.
Age: 67.0
Sex: M
Vaccine: CHIK, CHIK
Symptoms: Myalgia, Pyrexia, Tachycardia
Clinical narrative: Patient had myalgia on 10/11/2024. The following day patient had fever ranging between 100-102 degrees. Tachycardia of 160 BPM on 10/13/2024. Following day tachycardia continued at 149 BPM. At this point the clinic was called and these S/S reported. Pt advised to visit ER. Pt admitted on Monday to hospital. Pt was followed by cardiologist, IV medications given. Pt called to report hospitalization today 10/17/2024. Pt's wife reported that a chemical stress test and CT scan will be performed today regarding tachycardia.
Age: 67.0
Sex: M
Vaccine: CHIK, CHIK
Symptoms: Asthenia, Atrial flutter, Myalgia, Pain, Palpitations
Clinical narrative: Patient had myalgia on 10/11/2024. The following day patient had fever ranging between 100-102 degrees. Tachycardia of 160 BPM on 10/13/2024. Following day tachycardia continued at 149 BPM. At this point the clinic was called and these S/S reported. Pt advised to visit ER. Pt admitted on Monday to hospital. Pt was followed by cardiologist, IV medications given. Pt called to report hospitalization today 10/17/2024. Pt's wife reported that a chemical stress test and CT scan will be performed today regarding tachycardia.
Age: 67.0
Sex: M
Vaccine: CHIK, CHIK
Symptoms: Pyrexia, Tachycardia
Clinical narrative: Patient had myalgia on 10/11/2024. The following day patient had fever ranging between 100-102 degrees. Tachycardia of 160 BPM on 10/13/2024. Following day tachycardia continued at 149 BPM. At this point the clinic was called and these S/S reported. Pt advised to visit ER. Pt admitted on Monday to hospital. Pt was followed by cardiologist, IV medications given. Pt called to report hospitalization today 10/17/2024. Pt's wife reported that a chemical stress test and CT scan will be performed today regarding tachycardia.
Age: 44.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site rash
Clinical narrative: Rash around the injection site.
Age: 16.0
Sex: F
Vaccine: MNP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: 2x3 inch area of swelling, erythema and tenderness to arm at injection site starting 2 hours after vaccine. Low grade fever 100 max.
Age: 0.17
Sex: F
Vaccine: RV5
Symptoms: Vomiting
Clinical narrative: persistent vomiting
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia oral, Injection site erythema, Injection site pruritus, Paraesthesia oral
Clinical narrative: Redness and itching at the injection site started approximately 15 mins. after injection, followed by some tingling and numbness to the left side of the upper lip. Benadryl 25mgs. was administered with a good response.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt. was given the Spikevax COVID vaccine for people 12 years of age and older. Discussed with mother the potential side effects to watch for and when to notify us of any concerns.
Age: 0.67
Sex: M
Vaccine: DTAPHEPBIP, HEPA
Symptoms: Wrong product administered
Clinical narrative: Nurse took vaccines from someone else and did not check orders before going in and administering to patient. Patient was given 2 wrong vaccines (listed above) that was not ordered by the Doctor.
Age: 68.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Underdose
Clinical narrative: patient jerked their arm during administration resulting in some leakage and failure of the entire dose to be administered. the syringe was disposed of and patient did not receive the full amount.
Age: 80.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Fatigue, Heart rate irregular
Clinical narrative: Pt reported that within a couple hrs after injection he started to get tired, weak.  Specificallly mentioned his calves.  That same night he said his heart rate was acting erratic and he was losing energy.  He said this went on through the night.  He tried to treat with by taking 1/4 tab of 0.25mg alprazolam (0.0625MG).  He repeated this two more times (total of 3 X 1/4 tabs).  He said that finally helped.  Today (10/17) he called to tell me about this.  He reports that he is much improved and will not seek help unless it gets "bad" again tonight.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given outside of "Best By" date. Patient notified. No reaction stated
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Malaise, Product administered to patient of inappropriate age
Clinical narrative: Patient is 64. Called stating for 1 week after vaccine had headache and felt malaise. Reviewed documentation and patient received the Fluad vaccine instead of Fluarix. Denies any other symptoms and states these symptoms have resolved.
Age: 0.25
Sex: F
Vaccine: DTPPVHBHPB, PNC20, RV5
Symptoms: Inappropriate schedule of product administration, Vomiting projectile
Clinical narrative: Patient received their first dose of rotavirus at this office visit. Age of patient during this visit was 16 weeks and four days old. Oldest age first dose can be given is 14 weeks old. Following day patient was brought to ER for projectile vomiting.  Patient did recently receive 2 other vaccinations at PCP along with the Rotateq.  High suspicion for acute reaction/side effect from vaccinations.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given outside of "Best By" date. Patient notified. No reaction stated.
Age: 63.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: 3 days post-vaccination patient noticed a red, raised patch in the location of the injection, approximately the size of a nickle.  Patient reports it being itchy.  It has since grown to the size of a small clementine.  Patient is using ice and benadryl at home.  No other symtpoms.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Loss of consciousness
Clinical narrative: Patient came in to receive a Pneumovax 23. She was alert, oriented, talking before vaccination. About a minute after receiving the vaccine, patient passed out. Patient was unconscious for approximately one minute before coming to. Patient was transported to a local hospital via EMS.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt. was given the Spikevax COVID vaccine for people 12 years of age and older. Discussed with mother the potential side effects to watch for and when to notify us of any concerns.
Age: 88.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthenia, Blood alkaline phosphatase increased, Blood creatine phosphokinase increased
Clinical narrative: weakness, fever, elevated CK, acute hepatitis, thrombocytopenia
Age: 88.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Blood lactate dehydrogenase increased, Hepatitis acute, Platelet count decreased, Pyrexia, Thrombocytopenia
Clinical narrative: weakness, fever, elevated CK, acute hepatitis, thrombocytopenia
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Erythema, Peripheral swelling, Type III immune complex mediated reaction
Clinical narrative: She had an arthus type reaction left arm after 1st Antrax Vaccine. in Feb 2023  Lesser reactions after dose 2, and 3.  She had a larger more painful reaction after 4th dose. on 5/19/2024  It lasted  1 1/2 weeks.  Since then she has had a recurring arthus-type reaction with redness and swelling occur at random.  It was once a month, but now has happened twice in a month.  No constitutional symptoms.
Age: 44.0
Sex: M
Vaccine: COVID19, FLU3, HEP, HEPA, MMR, TDAP
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: As per our Region administered Spikevax 2023-2024 to client. We had been told to continue to utilize the Moderna Spikevax until expiration date 9/29/2024. No adverse reactions noted. Was told we must report it as a VAERS report.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered, Pain in extremity
Clinical narrative: Patient was seen at CLINIC on 9/23/24 and was given Flucelvax in the left deltoid. She went to Pharmacy on 10/14/24 and received Flulaval per patient's request. Patient stated that she thought she received Covid booster through us in September. Currently, only symptom is arm soreness.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, FLU3, PNC20
Symptoms: Rash, Tongue eruption
Clinical narrative: Pt had Pediarix, PCV20 and Flulaval 10/15/24, per mother rash over arms, legs, trunk and face started yesterday no other symptoms. Pt brought into clinic by mother today, afebrile, alert and smiling. Diffuse rash to face (area on tongue) trunk, arms and legs pt does not appear uncomfortable. PCM ordered antihistamine for mother to try, was picked up today
Age: 96.0
Sex: F
Vaccine: UNK
Symptoms: Activated partial thromboplastin time, Blood glucose, Chest X-ray, Computerised tomogram head, Computerised tomogram thorax
Clinical narrative: patient brought to emergency department for stroke like symptoms after receiving  an unknown brand/type of flu vaccine. unilateral facial droop and extremity flaccidity. speech difficulties. Admitted. physical therapy, occupational therapy, speech therapy.
Age: 96.0
Sex: F
Vaccine: UNK
Symptoms: Facial paralysis, Fibrin D dimer, Full blood count, Hypotonia, Lipids
Clinical narrative: patient brought to emergency department for stroke like symptoms after receiving  an unknown brand/type of flu vaccine. unilateral facial droop and extremity flaccidity. speech difficulties. Admitted. physical therapy, occupational therapy, speech therapy.
Age: 96.0
Sex: F
Vaccine: UNK
Symptoms: Magnetic resonance imaging head, Metabolic function test, Neurological symptom, Prohormone brain natriuretic peptide, Prothrombin time
Clinical narrative: patient brought to emergency department for stroke like symptoms after receiving  an unknown brand/type of flu vaccine. unilateral facial droop and extremity flaccidity. speech difficulties. Admitted. physical therapy, occupational therapy, speech therapy.
Age: 96.0
Sex: F
Vaccine: UNK
Symptoms: Speech disorder, Troponin, Ultrasound Doppler, Urine analysis
Clinical narrative: patient brought to emergency department for stroke like symptoms after receiving  an unknown brand/type of flu vaccine. unilateral facial droop and extremity flaccidity. speech difficulties. Admitted. physical therapy, occupational therapy, speech therapy.
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Dysstasia, Gait disturbance, Hypoaesthesia, Muscular weakness
Clinical narrative: Severe muscle weakness/numbness in both arms and legs the morning following the vaccine. Patient reports inability to stand or walk without assistance from spouse for several hours.
Age: 69.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Condition aggravated, Headache, Hypertension, Migraine
Clinical narrative: migraine starting one hour post injection and then continuous headache and high blood pressure
Age: 29.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site paraesthesia, Injection site swelling
Clinical narrative: Swelling, pain and tingling at the injection site. Pateint went to ER 3 days post immunization and was discharged with recommendation to take OTC ibuprofen and Icy Hot to the arm
Age: 12.0
Sex: M
Vaccine: DTAP, HEP
Symptoms: Influenza A virus test negative, Influenza B virus test negative, Neck pain, SARS-CoV-2 test negative
Clinical narrative: Right Side neck pain reported by mom and pt went to the hospital, 10/17/2024 @12:24p
Age: 40.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient came in and received a flu vaccine on 10/16/2024. Patient did not have an adverse reaction. It was later discovered that he also had a flu shot on 8/17/2024 at a different pharmacy. Therefore, the patient received two flu shots this season.
Age: 13.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Wrong product administered
Clinical narrative: MD ordered dose for patient to receive COVID 19 >12years vaccine. Medical assistant administered COVID 19 5-11 years vaccine.  MD notified in office. MD notified parent by phone after office visit that patient was given incorrect dose than what MD ordered.
Age: 35.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Chest discomfort, Pain in extremity
Clinical narrative: Chest tightness and discomfort when taking deep breaths. Alleviated by shower steam. Also arm soreness.
Age: 14.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: No known adverse effects, however 2023-2024 formulation was administered instead of 2024-2025. Provider will contact patient family to come back at 8 weeks minimum to readminister.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: There are no adverse effects. Patient did not remember that he got a flu shot and he registered for another one. He is not having any adverse effects.  Second flu shot given 10/16/24.
Age: 5.0
Sex: F
Vaccine: HEP, IPV, MMRV
Symptoms: Dizziness, Fall, Skin warm
Clinical narrative: Patient received 3 vaccines at approximately 0843. Patient and mother left patient room and went to lobby to pay administration fee.  While at counter, patient began to fall and mom caught her before hitting the ground. Mom reports patient did not eat before appointment. Patient given banana and crackers in lobby.  Clinic nurses brought patient back to room and assessed for any injuries.  None noted.  Blood pressure at 0856, 82/58. Pulse 64. Respirations 16. Skin warm to touch.  Alert and oriented. When asked about episode, patient stated she felt dizzy.  Patient continued to eat banana, crackers, a piece of chocolate and drink sips of water.  Patient observed for 15 minutes.  Patient reported feeling much better, with no dizziness. Patient and mother encouraged to continue eating and to monitor for any other symptoms.  Patient and mother encouraged to seek medical attention if any additional symptoms occur.
Age: 72.0
Sex: F
Vaccine: RSV, UNK
Symptoms: Infection, Swelling
Clinical narrative: Per Patient i received 2 vaccines and my arm got so swollen that resulted in infection and i am on my second antibiotic regimen
Age: 79.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Amnesia
Clinical narrative: PT reports having memory loss for about 20 minutes
Age: 80.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: Patient reported that her arm started feeling sore, and redness and swelling appeared the night she received the vaccine. She came to the pharmacy 3 days later for advice. Her arm was still red and swollen at the injection site and areas surrounding the site. The reaction is localized. She said the pain was relieved and there was no loss of range of motion.
Age: 16.0
Sex: F
Vaccine: COVID19, FLU3, MNQ
Symptoms: Underdose
Clinical narrative: MD ordered COVID >12 years vaccine for patient to receive. Medical assistant administered COVID 19 5-11years vaccine to patient. MD was notified in office. MD notified caregiver that patient was administered incorrect dose of vaccine via phone .
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Rash, Rash erythematous, Rash maculo-papular, Rash papular, Rash pruritic
Clinical narrative: Skin Problem Questionnaire Please describe your skin problem or concern, location, how long you have had this issue, and anything that makes it better or worse. Rash presenting on chest underneath both collarbones, as well as on ankles and tops of feet. - Describe onset and pattern (check all that apply): Sudden onset  Have you had a recent fever or are you currently running a fever? No  Symptoms and Exposures Do you have any of the following symptoms? (Please check all that apply) Itching, Rash - If other symptoms are present, please describe:Not necessarily hives, but textured lumps. Do you have a family member with a similar skin problem? No Have you ever had a similar problem in the past? Unsure Do you think you came in contact with something that caused the skin problem? Unsure                                                                                                  c/o rash that started 4 nights ago.  Rash is on upper chest and on medial ankles.  No improved with hydrocortisone cream and one dose of benadryl.  She has had some improvement today. The rash is itchy.   No mouth or throat swelling or SOB.  No fever.  No recent fever.   She had a flu shot on 10/8.    No other new exposures.   h/o eczema and child.     No eye, throat or vaginal symptoms.    pt reports as a child she previous received a particular "brand" of flu vaccine.      Preferred Pharmacy:   Medications Reviewed by LVN on 10/17/2024 3:49 PM Iron 325 (65 Fe) MG TABS; 1 TABLET ORALLY DAILY Mibelas 24 Fe 1-20 MG-MCG(24) TABLET CHEWABLE; 1 TABLET ORALLY DAILY FOR 28 DAYS   Allergies Reviewed by LVN on 10/17/2024 3:49 PM NO KNOWN DRUG ALLERGY NO KNOWN MATERIAL ALLERGY  No dietary or religious restrictions  Problem List Displayed items reviewed by employee on 10/17/2024 3:51:29 PM Problem List Iron deficiency anemia Surgery/Procedure None Hospitalization/Other None   OBJECTIVE Gen: in no acute distress Oropharynx: clear Cardiac: regular rate and rhythm without murmur Lungs: clear medial right ankle and chest:  splotchy, dry, erythematous, maculopapular (fine papules), slightly raised.    ASSESSMENT ER precautions given for mouth/throat swelling or SOB.  possible allergic reaction to flu vaccine. improving.  treat with BID Allegra and 5d of prednisone.        Diagnoses Rash and other nonspecific skin eruption (R21)   Encounter Code ESTAB PT W/ COMPLAINT LOW COMPLEXITY 99213   PLAN  Orders  MEDICATION ORDERS predniSONE 20 MG TABS ; 1 TABLET BY MOUTH TWICE A DAY; 5 DAYS; QTY 10 TABLET; 0 REFILLS (New) Rx Issued via Electronic (Network) PHARMACY  Comment to Pharmacy: Allergy List: NO KNOWN DRUG ALLERGY, and NO KNOWN MATERIAL ALLERGY Ordered by: MD HEALTH CENTER   Disposition FOLLOW-UP PRN WORSENING OR PERSISTENT SYMPTOMS
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Injected limb mobility decreased, Product administered at inappropriate site
Clinical narrative: Given both Moderna Covid 19 booster as well as flu vaccine injury due left arm. Within 3-4 hours of injection significant pain in left shoulder and inability to move arm up and down without significant pain. Have tried taking both ibuprofen and acetaminophen with very little relief. Upon examination of injection site it is noted vaccinations were given very high in the arm with high likelihood of hitting bursa and not deltoid. Symptoms are consistent with SILVA.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Given both Moderna Covid 19 booster as well as flu vaccine injury due left arm. Within 3-4 hours of injection significant pain in left shoulder and inability to move arm up and down without significant pain. Have tried taking both ibuprofen and acetaminophen with very little relief. Upon examination of injection site it is noted vaccinations were given very high in the arm with high likelihood of hitting bursa and not deltoid. Symptoms are consistent with SILVA.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Injected limb mobility decreased, Product administered at inappropriate site
Clinical narrative: Pt called pharmacy and said her arm was extremely sore and believes she was injected in her "shoulder"
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Pt called pharmacy and said her arm was extremely sore and believes she was injected in her "shoulder"
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Person with patient said the patient had a reaction a week after the vaccination.  No documentation but said had a stroke
Age: 29.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Feeling hot, Headache, Lethargy, Pain in extremity, Pyrexia
Clinical narrative: Got vaccines at 4:30 , went home and felt it arm soreness on my left and right around 7 when going to bed. Woke up feeling warm and lethargic, both arms hurt and had a slight headache . Throughout the day was sleeping and got a low grade fever. Took Tylenol later in the night to sleep to help with fever and headache .
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Embolism
Clinical narrative: The patient reports that she experienced multiple embolisms requiring hospitalization and medication
Age: 82.0
Sex: F
Vaccine: COVID19, FLU3, PNC21
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin warm
Clinical narrative: patient stated she had an itchy, red, hot, and swollen arm that went down to her elbow. it started on Friday and she called the doctor. they told her to go to urgent care and she was given an antibiotic and steroid to help. she also used cold compresses all weekend to help. she was told if it got worse, she was to go to the ER but that never happened.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Patient stated that she is experiencing tingling and numbness in her fingers, and radiates throughout her arm on the left arm.
Age: 0.17
Sex: F
Vaccine: RSV
Symptoms: Incorrect dose administered, Irritability
Clinical narrative: Infant of 2 months of given adult  Pfizer's Abrysvo.   Staff believed they were giving Beyfortus to infant. Mom did call the MD later that evening stating infant was irritable around 7:30 p.m.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Herpes zoster oticus
Clinical narrative: Diagnosed with a significant case of Shingles on 12/13/2023 and on 12/15/2023 with Ramsay Hunt
Age: 77.0
Sex: M
Vaccine: TDAP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Pt was given a second dose of boostrix after only 3 months. 1 dose 5/13/24, 2nd dose 8/30/24. Pt has not reported any adverse events.
Age: 85.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site swelling, Rash
Clinical narrative: pt reports swelling on the arm of the injection site as well as rash that has spread to the chest. advised pt to confer with pcp for treatment options
Age: 99.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pt received the first dose of Covid 19 Vaccine Comirnaty on 9/27/24. Accidently received the second dose of Comirnaty 10/16/24. No adverse reaction reported or noted  after closely monitoring  for the first 24 hours
Age: 1.5
Sex: M
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; HCP calling to report vaccines were administered after experiencing a temperature excursion.; This spontaneous report was received from a physician and referring to an 18 months old male patient. The patient's pertinent medical histories, concurrent conditions, previous drugs reactions or allergies and concomitant medications were not reported.   On 23-JUL-2024, the patient was vaccinated with second dose of improperly store hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, lot # X020849 which has been verified to be valid, expiration date reported and established as 26-DEC-2024 (strength, dose and vaccination scheme frequency were not provided) Intramuscularly in the left thigh for prophylaxis. The vaccine was administered after a temperature excursion of 8.8.1 degree Celsius (C) during a time frame of 4 minutes and 45 seconds (product storage error). No previous temperature excursion was reported. No additional adverse event (AE) was reported (no adverse event).  This is a case of multiple cases from the same reporter. ; Sender's Comments:  US-009507513-2410USA001607: US-009507513-2410USA001631:
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: Confirmed no other AE occurred.; The patient received a dose of VARIVAX after a temperature excursion.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided.  On 09-SEP-2024, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX), for prophylaxis (lot number (y003891 has been verified to be valid; and expiration date reported and established as 06-FEB-2026 (dosage, vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported) (product storage error). The administered dose of the vaccine was stored at a temperature of 10.2 degrees Fahrenheit (F), during a time frame of 1 hour 30 minutes. There was no previous temperature excursion reported. There was no adverse effect reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2410USA001590: US-009507513-2410USA001596:MSD US-009507513-2410USA001417:MSD US-009507513-2410USA001407:MSD
Sex: U
Vaccine: PNC15
Symptoms: No adverse event, Poor quality product administered
Clinical narrative: white floating particles.  He had shaken them but will not dissolved.; No AE; 2 syringes were already given to a patient; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On an unknown date, 8 syringes of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) 0.5 mL (reported as "VFC") had a lot of white floating particles that looked like a grains of salt, smaller than salt (liquid product physical issue). The reporter stated he had shaken them (agitation time reported as about 1 minute) but particles were not dissolved. Additionally, on 30-SEP-2024, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) 0.5 ml pre-filled syringe, 1 dose (reported as 1 DS), lot # reported and confirmed as: x026316, expiration date reported and confirmed as: 12-JAN-2026 (exact dose, dose number, site and route of administration were not provided) by a health professional (poor quality product administered) for prophylaxis. The reporter could not confirm that the dispensed syringes did or did not contain the particles. There was no additional adverse event (AE) reported.  This is one of two reports received from the same reporter. ; Sender's Comments:  US-009507513-2410USA006096:
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No further information provided. No additional Adverse Event reported; Nurse reports patient was accidently administered an expired dose of PNEUMOVAX 23 on Oct 15, 2024. Product expired on Oct 7, 2024.; This spontaneous report was received from licensed practical nurse and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 15-OCT-2024, the patient was vaccinated with an expired dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, once, lot #W029533 has been verified to be valid, expiration date reported and established as: 07-OCT-2024, administered for prophylaxis (strength, dose, and route of administration were not provided) (expired product administered). Product had no prior temperature excursions. No further information provided. No additional adverse event reported.
Sex: U
Vaccine: PNC15
Symptoms: No adverse event, Poor quality product administered
Clinical narrative: white floating particles.  He had shaken them but will not dissolved.; No AE; 2 syringes were already given to a patient; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On an unknown date, 8 syringes of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) 0.5 mL (reported as "VFC") had a lot of white floating particles that looked like a grains of salt, smaller than salt (liquid product physical issue). The reporter stated he had shaken them (agitation time reported as about 1 minute) but particles were not dissolved. Additionally, on 01-OCT-2024, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) 0.5 ml pre-filled syringe, 1 dose (reported as 1 DS), lot # reported and confirmed as: x026316, expiration date reported and confirmed as: 12-JAN-2026 (exact dose, dose number, site and route of administration were not provided) by a health professional (poor quality product administered) for prophylaxis. The reporter could not confirm that the dispensed syringes did or did not contain the particles. There was no additional adverse event (AE) reported.  This is one of two reports received from the same reporter ; Sender's Comments:  US-009507513-2410USA001994:
Sex: U
Vaccine: SMALLMNK
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient accidently received the second dose of Jynneos one week early; Case reference number US-BN-2024-002478 is a spontaneous case initially received from a nurse via Communications (reference number: USBAV24-2339) on 11-Sep-2024 and concerns a patient of unknown demographics.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, the patient was vaccinated with the first dose of Jynneos (batch number: unknown), at an unknown dose, route, and site of administration for protection against monkeypox.  On 11-Sep-2024, reported as one week early, the patient was vaccinated with the second dose of Jynneos (batch number: unknown), at an unknown dose, route and site of administration (explicitly coded as 'inappropriate schedule of vaccine administered').  At the time of the initial report, it was unknown if the patient experienced any adverse events due to Jynneos.  No further information was provided.; Reporter's Comments: A patient of unknown demographics was vaccinated with the second dose of Jynneos for protection against monkeypox, reported as one week early, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due to Jynneos. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown demographics was vaccinated with the second dose of Jynneos for protection against monkeypox, reported as one week early, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due to Jynneos. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Sex: U
Vaccine: SMALLMNK
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: The patient received second dose of Jynneos intramuscularly instead of subcutaneously; Case reference number US-BN-2024-002487 is a spontaneous case initially received from a pharmacist via agency (reference number: USBAV24-2357) on 12-Sep-2024 and concerns a patient of unknown demographics.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, the patient was vaccinated with the first dose of Jynneos (batch number: unknown), at an unknown dose, route, and site of administration for protection against monkeypox virus.  On 12-Sep-2024, an unknown amount of time after the first dose, the patient was vaccinated with the second dose of Jynneos (batch number: unknown), at an unknown dose, intramuscularly, at an unknown site of administration (explicitly coded as 'inappropriate route of vaccination').  As reported, the patient did not experience any adverse events due to Jynneos.  No further information was provided.; Reporter's Comments: A patient of unknown demographics was vaccinated with the second dose of Jynneos for protection against monkeypox virus, intramuscularly, which is considered as inappropriate route of vaccination. The patient did not experience any adverse events due to Jynneos. Incorrect route of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incorrect route of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown demographics was vaccinated with the second dose of Jynneos for protection against monkeypox virus, intramuscularly, which is considered as inappropriate route of vaccination. The patient did not experience any adverse events due to Jynneos. Incorrect route of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incorrect route of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Sex: U
Vaccine: SMALLMNK
Symptoms: Expired product administered
Clinical narrative: Patient received Jynneos vaccine three days after eight week thaw date; Case reference number US-BN-2024-002508 is a spontaneous case initially received from health care professional via  Communication (reference number: USBAV24-2406) on 17-Sep-2024 and concerns a patient of unspecified age or gender.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, the patient was vaccinated with the dose of Jynneos (batch number: unknown), at an unknown dose, route and site of administration for unknown indication. As reported patient received Jynneos vaccine three days after eight-week thaw date (explicitly coded as 'expired vaccine used').  At the time of the initial report, it was unknown if the patient experienced any adverse events due to Jynneos.  No further information was provided.; Reporter's Comments: A patient of unspecified age or gender was vaccinated with the dose of Jynneos, at an unknown dose, route and site of administration for unknown indication. Reportedly, the patient received Jynneos vaccine three days after eight-week thaw date which is considered as expired vaccine used. Expired product administered is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse events due to Jynneos. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A patient of unspecified age or gender was vaccinated with the dose of Jynneos, at an unknown dose, route and site of administration for unknown indication. Reportedly, the patient received Jynneos vaccine three days after eight-week thaw date which is considered as expired vaccine used. Expired product administered is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse events due to Jynneos. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Sex: U
Vaccine: SMALLMNK
Symptoms: Expired product administered
Clinical narrative: The patient received a dose of Jynneos vaccine three days past the eight-week period after thawing which was shelf life for the Jynneos after removing out of the fridge; Case reference number US-BN-2024-002507 is a spontaneous case report initially received from a nurse via agency (reference number USBAV24-2404) on 17-Sep-2024 and concerns a patient of unknown demographics.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, as reported three days past eight weeks after thawing which was the shelf life for the Jynneos after removed out of the fridge, the patient received a dose of Jynneos (batch number: unknown), at an unknown dose, route, or site of administration, for unknown indication (explicitly coded as 'expired vaccine used').  At the time of the initial report, it was unknown if the patient experienced any adverse event due to Jynneos vaccine.  No further information was provided.; Reporter's Comments: A patient of unknown demographics received a dose of Jynneos, three days past eight weeks after thawing which was the shelf life for the Jynneos after removed out of the fridge, at an unknown dose, route, or site of administration, for unknown indication which is considered as expired vaccine used. Expired product administered is considered listed per company conventions. At this point it was unknown if the patient experienced any adverse event due to Jynneos vaccine. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A patient of unknown demographics received a dose of Jynneos, three days past eight weeks after thawing which was the shelf life for the Jynneos after removed out of the fridge, at an unknown dose, route, or site of administration, for unknown indication which is considered as expired vaccine used. Expired product administered is considered listed per company conventions. At this point it was unknown if the patient experienced any adverse event due to Jynneos vaccine. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect route of product administration
Clinical narrative: The patient received intramuscularly the second dose of Jynneos vaccine; Case reference number US-BN-2024-002538 is a spontaneous case initially received from pharmacist via Communications (reference number USBAV24-2480) on 23-Sep-2024 and concerns a 32-years-old male patient.  The patient's medical history and concomitant medication details were not provided.  On an unspecified date, the patient received the first dose of Jynneos (batch number: 96867), at unknown dose or site of administration, subcutaneously, for prevention of smallpox and monkeypox disease.  On an unspecified date, unknown amount of time after the first dose of Jynneos vaccine, the patient received the second dose of Jynneos (batch number: 96867), at unknown dose or site of administration, intramuscularly (explicitly coded as 'Inappropriate route of vaccination').  At the time of the initial report, it was unknown if the patient experienced any adverse event due to Jynneos vaccine.  No further information was provided.; Reporter's Comments: A 32-years-old male patient received the second dose of Jynneos, unknown amount of time after the first dose of Jynneos vaccine, at unknown dose or site of administration, intramuscularly which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Jynneos vaccine. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 32-years-old male patient received the second dose of Jynneos, unknown amount of time after the first dose of Jynneos vaccine, at unknown dose or site of administration, intramuscularly which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Jynneos vaccine. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.